EUVIMEDOpdag EUVIMED
Crossref

Inhibition of XPR1‐dependent phosphate efflux induces mitochondrial dysfunction: A potential molecular target therapy for hepatocellular carcinoma?

Zi-Qiang Liao, Yang-Feng Lv, Mei-Diao Kang, Yu-Long Ji, Yue Liu, Le-Ran Wang, Jia-Liang Tang, Zhi-Qiang Deng, Yun Yi, Qun Tang iD

Molecular Carcinogenesis · 2024-12 · 63 (12) · 2332-2345

DOI: 10.1002/mc.23812 ↗

At a glance

Journal article in Molecular Carcinogenesis, published online on 2024-08-13. Written by Zi-Qiang Liao and 9 co-authors. Institution: The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, College of Pharmacy, Jiangxi Medical College, Nanchang Un…. Major MEDLINE topics: Carcinoma, Hepatocellular, Liver Neoplasms, Xenotropic and Polytropic Retrovirus Receptor, Cell Proliferation. Cited 5 times so far (Crossref); 70 references. Funded by: Natural Science Foundation of Jiangxi Province, National Natural Science Foundation of China.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Xenotropic and polytropic retrovirus receptor 1 (XPR1) is the only known transporter associated with Pi efflux in mammals, and its impact on tumor progression is gradually being revealed. However, the role of XPR1 in hepatocellular carcinoma (HCC) is unknown. A bioinformatics screen for the phosphate exporter XPR1 was performed in HCC patients. The expression of XPR1 in clinical specimens was analyzed using quantitative real‐time PCR, Western blot analysis, and immunohistochemical assays. Knockdown of the phosphate exporter XPR1 was performed by shRNA transfection to investigate the cellular phenotype and phosphate‐related cytotoxicity of the Huh7 and HLF cell lines. In vivo tests were conducted to investigate the tumorigenicity of HCC cells xenografted into immunocompromised mice after silencing XPR1. Compared with that in paracancerous tissue, XPR1 expression in HCC tissues was markedly upregulated. High XPR1 expression significantly correlated with poor patient survival. Silencing of XPR1 leads to decreased proliferation, migration, invasion, and colony formation in HCC cells. Mechanistically, knockdown of XPR1 causes an increase in intracellular phosphate levels; mitochondrial dysfunction characterized by reduced mitochondrial membrane potential and adenosine triphosphate levels; increased reactive oxygen species levels; abnormal mitochondrial morphology; and downregulation of key mitochondrial fusion, fission, and inner membrane genes. This ultimately results in mitochondria‐dependent apoptosis. These findings reveal the prognostic value of XPR1 in HCC progression and, more importantly, suggest that XPR1 might be a potential therapeutic target.

Subjects

MeSH terms (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsXenotropic and Polytropic Retrovirus ReceptorCell ProliferationPhosphatesHumansAnimalsMiceCell Line, TumorMitochondriaMaleGene Expression Regulation, NeoplasticXenograft Model Antitumor AssaysMolecular Targeted TherapyFemaleMice, NudeCell MovementMembrane Potential, MitochondrialApoptosisMiddle AgedReactive Oxygen SpeciesPrognosis

Author keywords

XPR1hepatocellular carcinomamitochondrion dysfunctionphosphate transporterprognostic markertherapeutic target

Substances

Xenotropic and Polytropic Retrovirus ReceptorXPR1 protein, humanPhosphatesReactive Oxygen Species

Authors and institutions

  • The MOE Basic Research and Innovation Center for the Targeted Therapeutics of Solid Tumors, College of Pharmacy, Jiangxi Medical College, Nanchang University, Nanchang, China.
  • Institute for Advanced Study, Nanchang University, Nanchang, China.
  • School of Public Health, Jiangxi Medical College, Nanchang University, Nanchang, China.
  • Queen Mary School, Jiangxi Medical College, Nanchang University, Nanchang, China.
  • Nanchang No. 2 High School, Nanchang, China.
  • Department of Oncology, The First People's Hospital of Fuzhou, Fuzhou, China.

ORCID profiles: Qun Tang

Funding

  • Natural Science Foundation of Jiangxi Province
  • National Natural Science Foundation of China

Cite

APA

Liao, Z. Q., Lv, Y. F., Kang, M. D., Ji, Y. L., Liu, Y., Wang, L. R., Tang, J. L., Deng, Z. Q., Yi, Y., & Tang, Q. (2024). Inhibition of XPR1‐dependent phosphate efflux induces mitochondrial dysfunction: A potential molecular target therapy for hepatocellular carcinoma?. Molecular Carcinogenesis, 63(12), 2332-2345. https://doi.org/10.1002/mc.23812

Vancouver

Liao ZQ, Lv YF, Kang MD, Ji YL, Liu Y, Wang LR, et al. Inhibition of XPR1‐dependent phosphate efflux induces mitochondrial dysfunction: A potential molecular target therapy for hepatocellular carcinoma?. Molecular Carcinogenesis. 2024;63(12):2332-2345. doi:10.1002/mc.23812

BibTeX
@article{Liao2024,
  author = {Liao, Zi-Qiang and Lv, Yang-Feng and Kang, Mei-Diao and Ji, Yu-Long and Liu, Yue and Wang, Le-Ran and Tang, Jia-Liang and Deng, Zhi-Qiang and Yi, Yun and Tang, Qun},
  title = {Inhibition of XPR1‐dependent phosphate efflux induces mitochondrial dysfunction: A potential molecular target therapy for hepatocellular carcinoma?},
  journal = {Molecular Carcinogenesis},
  year = {2024},
  volume = {63},
  number = {12},
  pages = {2332--2345},
  doi = {10.1002/mc.23812}
}
Start for free →